Katie Kosko

From a weight loss drug’s possible cancer risk to a shocking cancer revelation in the death of ESPN reporter Edward Aschoff, here’s what is making headlines in the cancer space this week.

With many targeted treatment options for patients with CLL to use upfront, the question arises as to which one is best for the individual.

The medication plinabulin is currently being tested in clinical trials to see its benefits in treating chemotherapy-induced neutropenia.

In this week’s episode of the “CURE Talks Cancer” podcast, we spoke with breast cancer survivor Felicia Robinson, who recently wrote a book with her daughter on their personal experiences with the various aspects of a life-changing diagnosis.

From Alex Trebek talking chemotherapy for his pancreatic cancer and his final “Jeopardy!” show to the passing of World Series Legend Don Larsen, here’s what is making headlines in the cancer space this week.

Patients with unresectable or metastatic HER2-positive breast cancer now have a new treatment option.

From a newly proposed rule to help lower prescription drug prices to an oncology nurse and a patient with cancer singing “O Holy Night,” here’s what is making headlines in the cancer space this week.

Patients with hepatocellular carcinoma whose tumors couldn’t be surgically removed lived longer and experienced few side effects after stereotactic body radiotherapy, according to phase 2 study findings.

Patients with head and neck cancer who received acupuncture during therapy saw lower incidence and severity of dry mouth compared with those who received oral health education.

Survival and recurrence rates were similar among patients with breast cancer who either received accelerated partial breast irradiation or whole breast irradiation.

From a bill that would improve access to care for patients with stage 4 cancer to the death of Roxette lead singer Marie Fredrikksson, here’s what is making headlines in the cancer space this week.

Women treated with Arimidex for five years were 50% less likely to have developed breast cancer recurrence compared with women given placebo at nearly 11 years follow-up after stopping treatment.

Nearly 65% of patients whose disease had spread to lymph nodes showed no signs of cancer following a regimen of Keytruda plus chemotherapy compared with those who received chemotherapy alone.

In a phase 3 clinical trial, Blincyto (blinatumomab), a type of immunotherapy, improved survival and showed fewer side effects in young patients.

A phase 3 clinical trial investigating Fotivda improved chances of preventing disease progression in patients with kidney cancer compared with Nexavar.

A dual-targeted chimeric antigen receptor-T cell therapy showed a more than 90% overall response rate in patients with relapsed or refractory disease.

JNJ-4528 showed deep responses and proved to be safe in patients with multiple myeloma, according to CARTITUDE-1 study findings.

From better breast cancer screening options for service members and their families to a Christmas display that’s raising cancer awareness, here’s what is making headlines in the cancer space this week.

Two-time cancer survivor Anne Weber feels fortunate to have learned of her BRCA2 gene mutation, as it led to an early diagnosis of aggressive breast cancer.

From the first patient death under the Right to Try law to a 9-year-old ovarian cancer survivor meeting her hero Jim Cantore, here’s what is making headlines in the cancer space this week.

In this week’s “CURE Talks Cancer” podcast, we spoke with Michelle Velez, who developed a rare gynecological cancer following a molar pregnancy.

Here’s a look at what’s inside our November 2019 Lung Cancer special issue.

Meet four patients with multiple myeloma who have found hope and improved quality of life by participating in endurance events.

Researchers developed SurVaxM to help stimulate an immune response in patients with glioblastoma.

Here is a list of the recent trial initiations that occurred within the myeloproliferative neoplasm cancer space.

How one mother learned that “broken hearts still beat.”

A melanoma expert addresses the findings of two studies on the disease in children, adolescents and young adults, and shares ways in which they can protect themselves.

From plans to sue the School District of Philadelphia over a mesothelioma diagnosis to Dwayne “The Rock” Johnson singing for a 3-year-old with acute lymphoblastic leukemia, here’s what is making headlines in the cancer space this week.

Researchers combine therapies in clinical trials to find the best match for patients with small cell lung cancer.

The Food and Drug Administration approved Brukinsa to treat relapsed and refractory mantle cell lymphoma, but what does this mean for patients?